150 related articles for article (PubMed ID: 38085929)
1. Leukocyte Telomere Length and the Risk of Prostate Cancer and Benign Prostatic Hyperplasia: Insights From UK Biobank and Mendelian Randomization Study.
Lv K; Wu Y; Yang G; Hao X; Huang S; Song T; Yuan Q
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 38085929
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization study on the causal relationship between leukocyte telomere length and prostate cancer.
Wan B; Lu L; Lv C
PLoS One; 2023; 18(6):e0286219. PubMed ID: 37352282
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte telomere length and bipolar disorder risk: evidence from Mendelian randomization analysis.
Lu L; Zeng H; Wan B; Sun M
PeerJ; 2023; 11():e15129. PubMed ID: 37020849
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte telomere length is associated with increased risk of endometriosis: a bidirectional two-sample Mendelian randomization study.
Bai C; Shen Z; Qiu B; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1272200. PubMed ID: 38034012
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization study supports positive bidirectional causal relationships between genetically predicted insomnia symptom and liability to benign prostatic hyperplasia.
Li N; Yang K; Deng L; Zeng Y; Cao S; Chen D
BMC Urol; 2024 Apr; 24(1):91. PubMed ID: 38643096
[TBL] [Abstract][Full Text] [Related]
7. Identifying effects of genetic obesity exposure on leukocyte telomere length using Mendelian randomization.
Wan B; Ma N; Lv C
PeerJ; 2023; 11():e15085. PubMed ID: 36967999
[TBL] [Abstract][Full Text] [Related]
8. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.
Wang YB; Yang L; Deng YQ; Yan SY; Luo LS; Chen P; Zeng XT
J Transl Med; 2022 Oct; 20(1):495. PubMed ID: 36309747
[TBL] [Abstract][Full Text] [Related]
9. The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
Lv K; Yang G; Wu Y; Xia X; Hao X; Pang A; Han D; Yuan Q; Song T
Prostate; 2023 Oct; 83(14):1358-1364. PubMed ID: 37455410
[TBL] [Abstract][Full Text] [Related]
10. Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study.
Li Y; Yang S; Liao M; Zheng Z; Li M; Wei X; Liu M; Yang L
Front Immunol; 2022; 13():1072573. PubMed ID: 36798520
[TBL] [Abstract][Full Text] [Related]
11. A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study.
Liao Q; He J; Tian FF; Bi FF; Huang K
Front Immunol; 2022; 13():922922. PubMed ID: 35911771
[TBL] [Abstract][Full Text] [Related]
12. Exploring Causal Relationships between Leukocyte Telomere Length, Sex Hormone-Binding Globulin Levels, and Osteoporosis Using Univariable and Multivariable Mendelian Randomization.
Sun K; Li M; Wu Y; Wu Y; Zeng Y; Zhou S; Peng L; Shen B
Orthop Surg; 2024 Feb; 16(2):320-328. PubMed ID: 38084376
[TBL] [Abstract][Full Text] [Related]
13. Modifiable traits, healthy behaviours, and leukocyte telomere length: a population-based study in UK Biobank.
Bountziouka V; Musicha C; Allara E; Kaptoge S; Wang Q; Angelantonio ED; Butterworth AS; Thompson JR; Danesh JN; Wood AM; Nelson CP; Codd V; Samani NJ
Lancet Healthy Longev; 2022 May; 3(5):e321-e331. PubMed ID: 35685390
[TBL] [Abstract][Full Text] [Related]
14. Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study.
Wei D; Jiang Y; Cheng J; Wang H; Sha K; Zhao J
Front Immunol; 2023; 14():1023991. PubMed ID: 37033949
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank.
Wong JY; Blechter B; Hubbard AK; Machiela MJ; Shi J; Gadalla SM; Hu W; Rahman ML; Rothman N; Lan Q
Thorax; 2024 Feb; 79(3):274-278. PubMed ID: 38238005
[TBL] [Abstract][Full Text] [Related]
16. Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study.
Loh NY; Rosoff D; Noordam R; Christodoulides C
Obesity (Silver Spring); 2023 Aug; 31(8):2189-2198. PubMed ID: 37415075
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte telomere length and sarcopenia-related traits: A bidirectional Mendelian randomization study.
Wang D; Li C; Zhang X; Li Y; He J; Guo X
PLoS One; 2024; 19(1):e0296063. PubMed ID: 38166034
[TBL] [Abstract][Full Text] [Related]
18. Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study.
Xia D; Wang J; Zhao X; Shen T; Ling L; Liang Y
Front Cell Infect Microbiol; 2023; 13():1248381. PubMed ID: 37799337
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the causal effects of leukocyte telomere length and four gastrointestinal diseases: a two-sample bidirectional Mendelian randomization study.
Wang H; Chen X; Wang S; Zhang H
BMC Gastroenterol; 2023 Dec; 23(1):446. PubMed ID: 38110867
[TBL] [Abstract][Full Text] [Related]
20. Association between COVID-19 and telomere length: A bidirectional Mendelian randomization study.
Huang D; Lin S; He J; Wang Q; Zhan Y
J Med Virol; 2022 Nov; 94(11):5345-5353. PubMed ID: 35854470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
